Photo: ViewStock/Getty Images

照片：ViewStock/Getty Images

Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company's newly appointed CEO.

管理糖尿病和其他慢性病的数字平台制造商Glooko已获得一亿美元的F系列资金，并宣布迈克·阿尔瓦雷斯（MikeAlvarez）为公司新任首席执行官。

Georgian led the round with participation from Canaan, Health Catalyst Capital, and other investors and business partners.

格鲁吉亚领导了这轮谈判，来自迦南、Health Catalyst Capital以及其他投资者和商业伙伴。

Alvarez formerly held the CEO role at Qardio, a remote patient monitoring and healthcare technology company for chronic disease management. Before that, he held leadership positions at medical device maker Medtronic, pharma company Sanofi and St. Jude Medical, which was acquired by Abbott.

阿尔瓦雷斯曾在Qardio担任首席执行官，Qardio是一家远程患者监测和医疗保健技术公司，负责慢性病管理。在此之前，他曾在医疗器械制造商美敦力、制药公司赛诺菲和被雅培收购的圣裘德医疗担任领导职务。

WHAT IT DOES

它的功能

Glooko offers healthcare technology and a personalized, connected healthcare platform for individuals with chronic conditions to help manage their condition. The company works with providers, offering a remote patient management platform, research products for clinical trials and medical devices for managing conditions. .

Glooko为慢性病患者提供医疗保健技术和个性化、互联的医疗保健平台，帮助他们管理病情。该公司与供应商合作，提供远程患者管理平台、临床试验研究产品和用于管理病情的医疗设备。。

The California-based company will use the funds to scale its product expansion globally.

这家总部位于加利福尼亚的公司将利用这些资金在全球范围内扩大产品扩张规模。

'The healthcare industry is currently navigating significant challenges related to data burden and clinical workflows, particularly for physicians working with patients to manage chronic conditions,' Alvarez said in a statement.

阿尔瓦雷斯在一份声明中说：“医疗保健行业目前面临着与数据负担和临床工作流程相关的重大挑战，特别是对于与患者合作管理慢性病的医生来说。”。

'I am thrilled to join Glooko at this pivotal moment in its journey. I look forward to continued commercial acceleration as we leverage real-world data to transform chronic condition management and improve enrollment and management in clinical trials through diverse and inclusive populations.'

“我很高兴在Glooko旅程的关键时刻加入它。随着我们利用现实世界的数据来改变慢性病管理，并通过多样化和包容性的人群改善临床试验的注册和管理，我期待着继续加速商业化。”

MARKET SNAPSHOT

市场快照

In January, Glooko announced a partnership with Better Therapeutics to integrate the digital therapeutics company's AspyreRx digital behavioral treatment for type 2 diabetes into Glooko’s diabetes management platform.

1月，Glooko宣布与Better Therapeutics合作，将数字治疗公司的AspyreRx 2型糖尿病数字行为治疗整合到Glooko的糖尿病管理平台中。

Last year, the company announced a partnership with pharma company Sanofi to integrate SoloSmart with the Glooko platform. SoloSmart is a device intended for use with SoloStar and DoubleStar insulin injection pens, which records insulin data and time of injection and allows users to see that data via the Glooko app. .

去年，该公司宣布与制药公司赛诺菲合作，将SoloSmart与Glooko平台集成。SoloSmart是一种用于SoloStar和DoubleStar胰岛素注射笔的设备，它记录胰岛素数据和注射时间，并允许用户通过Glooko应用程序查看这些数据。。

In 2022, the company acquired Berlin-based xbird, a health AI company that develops Just In Time Adaptive Intervention technologies for patients and providers to predict behavior and manage diabetes.

2022年，该公司收购了总部位于柏林的xbird，这是一家健康人工智能公司，为患者和提供者开发即时适应性干预技术，以预测行为和管理糖尿病。

It also purchased Paris-based DIABNEXT, a company that offers a digital health platform to help people with diabetes manage their condition and connect with their healthcare provider.

。

In 2021, Glooko raised $30 million in Series D funding in a round led by Health Catalyst Capital.

2021年，Glooko在Health Catalyst Capital领导的一轮D系列融资中筹集了3000万美元。

Tags: Glooko, digital diabetes, chronic disease management

标签：Glooko，数字糖尿病，慢性病管理

More regional news

更多地区新闻

Microsoft extends AI capabilities for healthcare data solutionsBy Anthony VecchioneOctober 11, 2024

Microsoft为医疗保健数据解决方案扩展AI功能作者：AnthonyVecchione2024年10月11日

Patient engagement platform RadiantGraph garners $11MBy Jessica HagenOctober 10, 2024

患者参与平台RadiantGraph获得1100万美元Jessica HagenOctober 10204

New HIMSS Analytics Maturity Assessment Model supports smart AI deploymentsBy Mike MiliardOctober 10, 2024

新的HIMSS分析成熟度评估模型支持智能AI部署，由Mike Miliard2024年10月10日发布